Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.

Date publication

février 2020

Journal

Cancer medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LACOUR Brigitte

Tous les auteurs :
Butel T, Karanian M, Pierron G, Orbach D, Ranchere D, Cozic N, Galmiche L, Coulomb A, Corradini N, Lacour B, Proust S, Guerin F, Boutroux H, Rome A, Mansuy L, Vérité C, Defachelles AS, Tirode F, Minard-Colin V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32087612

Résumé

Rhabdomyosarcoma (RMS) in infants is a particular entity with various clinical presentations and outcomes. To better understand the clinical heterogeneity of RMS in infants, an integrative clinical, histological, and molecular analysis was performed.

Mots clés

VGLL2, infants, newborns, rhabdoid tumor, rhabdomyosarcoma, spindle cell rhabdomyosarcoma

Référence

Cancer Med. 2020 Feb 22;: